Can Fite Bio (CANF) Financial Statements

3 Followers

Can Fite Bio Financial Overview

Can Fite Bio's market cap is currently ₪20.76M. The company's EPS TTM is 0; its P/E ratio is ―; Can Fite Bio is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is -73.98. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 438.40K	$ 674.00K	$ 743.00K	$ 810.00K	$ 853.00K
Gross Profit	$ 412.42K	$ 674.00K	$ 743.00K	$ 810.00K	$ 853.00K
Operating Income	$ -10.77M	$ -8.13M	$ -8.20M	$ -10.10M	$ -12.84M
EBITDA	$ -10.74M	$ -8.12M	$ -8.18M	$ -10.08M	$ -12.83M
Net Income	$ -10.64M	$ -7.88M	$ -7.63M	$ -10.17M	$ -12.60M
Balance Sheet
Cash & Short-Term Investments	$ 8.54M	$ 7.89M	$ 8.92M	$ 7.98M	$ 19.14M
Total Assets	$ 9.52M	$ 9.12M	$ 9.99M	$ 9.28M	$ 20.25M
Total Debt	$ 71.01K	$ 104.00K	$ 40.00K	$ 62.00K	$ 124.00K
Net Debt	$ -5.46M	$ -4.72M	$ -4.24M	$ -2.92M	$ -4.27M
Total Liabilities	$ 3.92M	$ 3.68M	$ 3.75M	$ 4.81M	$ 5.87M
Stockholders' Equity	$ 5.59M	$ 5.44M	$ 6.24M	$ 4.47M	$ 14.38M
Cash Flow
Free Cash Flow	$ -9.69M	$ -7.64M	$ -8.44M	$ -10.81M	$ -9.87M
Operating Cash Flow	$ -9.69M	$ -7.64M	$ -8.44M	$ -10.80M	$ -9.86M
Investing Cash Flow	$ -2.16K	$ 1.50M	$ 498.00K	$ 9.50M	$ -14.51M
Financing Cash Flow	$ 10.44M	$ 6.71M	$ 9.14M	$ 0.00	$ 20.46M

Currency in USD

Can Fite Bio Earnings and Revenue History

Income Statement >

Can Fite Bio Debt to Assets

Balance Sheet >

Can Fite Bio Cash Flow

Cash Flow >

Can Fite Bio Forecast EPS vs Actual EPS

Earnings >